Filing Flows › 10x Genomics (TXG) › Services revenue
10x Genomics (TXG) Services revenue by quarter
10x Genomics' Services revenue was $9.0M in Q3 2026 (third quarter 2026), -16% from Q2 2026. Over the last 7 quarters it ranged from $7.7M (Q1 2025) to $10.7M (Q2 2026).
| Quarter | Services revenue | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $9.0M | -16% | +11% |
| Q2 2026 | $10.7M | +21% | +26% |
| Q1 2026 | $8.8M | +4% | +15% |
| Q4 2025 | $8.5M | +4% | — |
| Q3 2025 | $8.1M | -4% | — |
| Q2 2025 | $8.5M | +11% | — |
| Q1 2025 | $7.7M | — | — |
Q3 2026 at a glance
10x Genomics, Q3 2026: revenue $151M (+1% year over year), operating margin -10.7%, net loss $19.4M, operating cash flow $15.8M. The chart follows the revenue to costs, profit and cash.
Questions
What is 10x Genomics' Services revenue?
10x Genomics' Services revenue was $9.0M in Q3 2026 (third quarter 2026), -16% from Q2 2026.
How has 10x Genomics' Services revenue changed?
Over the last 7 quarters it ranged from $7.7M (Q1 2025) to $10.7M (Q2 2026).